10-Q/A 1 umed10q_a1june02.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 Quarterly Report Under Section 13 or 15(d) of The Securities Exchange Act of 1934 For quarter ended: June 30, 2002 Commission File No. 0-11178 ------- UTAH MEDICAL PRODUCTS, INC. --------------------------- (Exact name of Registrant as specified in its charter) UTAH 87-0342734 ------------------------------- ------------------ (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) 7043 South 300 West Midvale, Utah 84047 --------------------- Address of principal executive offices Registrant's telephone number: (801) 566-1200 -------------- Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Sections 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and; (2) has been subject to such filing requirements for the past 90 days. Yes X No --- -- The number of shares outstanding of the registrant's common stock as of August 13, 2002: 4,905,000 --------- PART II - OTHER INFORMATION Item 4. Submission of Matters to a Vote of Security Holders On May 10, 2002 at the annual meeting, shareholders of the Company approved the following matter submitted to them for consideration: Elected Stephen W. Bennett and Ernst G. Hoyer as directors of the Company. Stephen W. Bennett: For 4,612,140 Ernst G. Hoyer: For 4,612,140 SIGNATURES Pursuant to the requirements of the Securities Exchanges Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. UTAH MEDICAL PRODUCTS, INC. REGISTRANT Date: 8/14/02 By: /s/ Kevin L. Cornwell -------------- ------------------------------ Kevin L. Cornwell CEO